Skip to Content

What is Rydapt used to treat?

Medically reviewed by Last updated on Jun 25, 2019.

Official Answer


Rydapt (midostaurin) from Novartis Pharmaceuticals is an oral, multi-targeted kinase inhibitor approved to treat acute myeloid leukemia (AML). Rydapt is for patients who have been newly-diagnosed with an FMS-like tyrosine kinase-3 (FLT3) mutation, and can be used to treat advanced systemic mastocytosis (SM), which includes aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN) and mast cell leukemia.

Related Medical Questions

Drug Information

Related Support Groups